Dual-energy X-ray absorptiometry is widely used to screen for osteoporosis and, with further research, may double as a tool to assess ASCVD risk without added cost or radiation exposure.
Radiologists and other clinicians may use 3D-amplified MRI as a complement to guide their treatment decision-making, according to recently published research papers.